Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

by Armenteros, J.J.A, Bayarri-Olmos, R., Biering-Sørensen, T., Browatzki, A., Bundgaard, H., Fogh, K., Frikke-Schmidt, R., Garred, P., Hamm, S.R, Hansen, C.B, Harboe, Z.B, Hasselbalch, R.B, Heftdal, L.D, Hilsted, L., Iversen, K.K, Jensen, J.-U.S, Kjeldgaard, P., Lindegaard, B., Madsen, J.R, Møller, D.L, Nielsen, S.D, Ostrowski, S.R, Pérez-Alós, L., Priemé, H., Pries-Heje, M.M, Shaker, S., Sivapalan, P., Sørensen, E., Svorre Jordan, A., Wilcke, T.
Published 2022